United AirlInes UAL stock

AlloVir is lay­ing off 95% of its work­ers to “re­duce costs and pre­serve cap­i­tal” af­ter dis­con­tin­u­ing three Phase III tri­als of its an­tivi­ral cell ther­a­py

An oral ver­sion of No­vo Nordisk’s semaglu­tide helped pa­tients tak­ing the high­est dose lose 15% of their body weight. It’s on par with No­vo’s We­govy,